
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ABT | NYSE | USD | Real-time | |
0Q15 | London | USD | Real-time | |
ABT | Mexico | MXN | Delayed | |
ABT | Switzerland | CHF | Delayed | |
ABT | TradeGate | EUR | Delayed | |
ABT | Xetra | EUR | Delayed | |
ABT | Frankfurt | EUR | Delayed | |
ABTCL | Santiago | CLP | Delayed | |
ABT | Santiago | USD | Delayed | |
ABT | Buenos Aires | ARS | Delayed | |
ABTT34 | BM&FBovespa | BRL | Delayed | |
ABT_KZ | KASE | USD | Delayed |
Abbott Laboratories reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was USD 10,091 million compared to USD 11,468 million a year ago. Net income was USD 1,033 million compared to USD 1,989 million a year ago. Diluted earnings per share from continuing operations was USD 0.59 compared to USD 1.11 a year ago.
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 10091 | 10410 | 11257 | 11895 |
Gross Profit | 5561 | 5781 | 6324 | 6908 |
Operating Income | 1459 | 1872 | 2482 | 3011 |
Net Income | 1033 | 1435 | 2018 | 2447 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 74438 | 72801 | 74202 | 74007 |
Total Liabilities | 37533 | 36917 | 37486 | 38378 |
Total Equity | 36905 | 35884 | 36716 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 2326 | 2780 | 2410 | 2065 |
Cash From Investing Activities | -632 | -484 | -264 | -360 |
Cash From Financing Activities | -1457 | -1543 | -813 | -3823 |
Net Change in Cash | 288 | 657 | 1262 | -2124 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review